Systemic Therapy for Soft Tissue Sarcoma: Proposals for the Optimal Use of Pazopanib, Trabectedin, and Eribulin
Crossref DOI link: https://doi.org/10.1007/s12325-017-0561-4
Published Online: 2017-05-25
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kawai, Akira
Yonemori, Kan
Takahashi, Shunji
Araki, Nobuhito
Ueda, Takafumi
Funding for this research was provided by:
Eisai
Text and Data Mining valid from 2017-05-25
Article History
Received: 31 March 2017
First Online: 25 May 2017